R. Brigg Turner

Review and Validation of Bayesian Dose‐Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients

R. Brigg Turner, Kyle Kojiro, Emily A. Shephard et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2018 · 128 citations

Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy

Shauna Jacobson Junco, Mary Catherine Bowman, R. Brigg Turner · International Journal of Antimicrobial Agents · 2021 · 54 citations

Health Sciences, Antibiotics, Fluoroquinolone Monotherapy +8

Impact of an Antimicrobial Stewardship Program on Antibiotic Use at a Nonfreestanding Children's Hospital

R. Brigg Turner, Elena Valcarlos, Ann M. Loeffler et al. · Journal of the Pediatric Infectious Diseases Society · 2016 · 31 citations

Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System

R. Brigg Turner, Elena Valcarlos, Regina Won et al. · Antimicrobial Agents and Chemotherapy · 2016 · 30 citations · Full text

Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population

R. Brigg Turner, Kyle Kojiro, Regina Won et al. · Diagnostic Microbiology and Infectious Disease · 2018 · 30 citations

Critical Care Medicine, Antibiotics, Vancomycin Pharmacokinetics +8